Understanding influenza vaccine protection in the community: An assessment of the 2013 influenza season in Victoria, Australia

Highlights • Estimating vaccine effectiveness (VE) is an important component of influenza surveillance. • The 2013 influenza season in Victoria, Australia, was characterised by low activity with a late peak. • Adjusted VE for influenza: 53% (95%CI: −16, 81); with imputation of missing data: 62% (95%...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2015-01, Vol.33 (2), p.341-345
Hauptverfasser:	Carville, Kylie S, Grant, Kristina A, Sullivan, Sheena G, Fielding, James E, Lane, Courtney R, Franklin, Lucinda, Druce, Julian, Kelly, Heath A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Allergy and Immunology Case-Control Studies Female Humans Influenza Influenza A Virus, H1N1 Subtype - immunology Influenza A Virus, H3N2 Subtype - immunology Influenza B virus - immunology Influenza season Influenza vaccine Influenza Vaccines - immunology Influenza virus Influenza, Human - prevention & control Influenza-like illness Laboratories Middle Aged Mortality Odds Ratio Pandemics Seasons Sentinel Surveillance Surveillance Time Factors Vaccination Vaccine effectiveness Vaccines Victoria - epidemiology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Estimating vaccine effectiveness (VE) is an important component of influenza surveillance. • The 2013 influenza season in Victoria, Australia, was characterised by low activity with a late peak. • Adjusted VE for influenza: 53% (95%CI: −16, 81); with imputation of missing data: 62% (95%CI: 8, 84). • TIV may prevent at least 50% of laboratory-confirmed outcomes in the community.
ISSN:	0264-410X 1873-2518
DOI:	10.1016/j.vaccine.2014.11.019